Paper20157737
DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.
Zipfel PF and 6 others. Pediatr Nephrol, 2010. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Papers, record 20157737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20157737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoantibodies | Major topic |
| Complement Factor H | Major topic |
| Hemolytic-Uremic Syndrome | Major topic |
| Autoantigens | |
| Blood Proteins | |
| Child | |
| Complement C3b Inactivator Proteins | |
| Humans |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17495132 | Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. | Blood | 2007 | https://conductscience.org/library/papers/17495132 | PubMed |
| 2 | 19666655 | Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome. | Nephrol Dial Transplant | 2010 | https://conductscience.org/library/papers/19666655 | PubMed |
| 3 | 19730437 | Complement regulators and inhibitory proteins. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19730437 | PubMed |
| 4 | 19179328 | Eculizumab for atypical hemolytic-uremic syndrome. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19179328 | PubMed |
| 5 | 12697737 | Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12697737 | PubMed |
| 6 | 15890682 | ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. | Blood | 2005 | https://conductscience.org/library/papers/15890682 | PubMed |
| 7 | 19861685 | Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. | Blood | 2010 | https://conductscience.org/library/papers/19861685 | PubMed |
| 8 | 8428964 | A novel short consensus repeat-containing molecule is related to human complement factor H. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8428964 | PubMed |
| 9 | 19531976 | Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. | Pediatr Res | 2009 | https://conductscience.org/library/papers/19531976 | PubMed |
| 10 | 18006700 | Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. | Blood | 2008 | https://conductscience.org/library/papers/18006700 | PubMed |
| 11 | 19821824 | Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. | Br J Haematol | 2010 | https://conductscience.org/library/papers/19821824 | PubMed |
| 12 | 3182017 | Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man. | Immunogenetics | 1988 | https://conductscience.org/library/papers/3182017 | PubMed |
| 13 | 16634809 | The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. | Clin Exp Immunol | 2006 | https://conductscience.org/library/papers/16634809 | PubMed |
| 14 | 1533657 | Two additional human serum proteins structurally related to complement factor H. Evidence for a family of factor H-related genes. | J Immunol | 1992 | https://conductscience.org/library/papers/1533657 | PubMed |
| 15 | 15163532 | The human complement factor H: functional roles, genetic variations and disease associations. | Mol Immunol | 2004 | https://conductscience.org/library/papers/15163532 | PubMed |
| 16 | 15728781 | Hemolytic uremic syndrome. | J Am Soc Nephrol | 2005 | https://conductscience.org/library/papers/15728781 | PubMed |
| 17 | 17076561 | Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. | PLoS Med | 2006 | https://conductscience.org/library/papers/17076561 | PubMed |
| 18 | 11158219 | The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. | J Am Soc Nephrol | 2001 | https://conductscience.org/library/papers/11158219 | PubMed |
| 19 | 28950782 | Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications. | Ann Med | 2006 | https://conductscience.org/library/papers/28950782 | PubMed |
| 20 | 17229916 | Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. | J Am Soc Nephrol | 2007 | https://conductscience.org/library/papers/17229916 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972150 | Unraveling Immune Dysregulation in ZNFX1 Deficiency: From Interferonopathies to Macrophage Activation Syndrome. | J Clin Immunol | 2026 | https://conductscience.org/library/papers/42972150 | PubMed |
| 42831904 | STEC-triggered DEAP-HUS in a toddler: successful management with eculizumab and mycophenolate mofetil without corticosteroids. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42831904 | PubMed |
| 42048291 | Thrombotic Microangiopathy in Childhood Steroid-Resistant Nephrotic Syndrome: Case Series. | Nephron | 2026 | https://conductscience.org/library/papers/42048291 | PubMed |
| 40371898 | Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab. | Haematologica | 2025 | https://conductscience.org/library/papers/40371898 | PubMed |
| 39534179 | C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation. | Front Nephrol | 2024 | https://conductscience.org/library/papers/39534179 | PubMed |
| 39136026 | Factor H-related protein 1 in systemic lupus erythematosus. | Front Immunol | 2024 | https://conductscience.org/library/papers/39136026 | PubMed |
| 37744338 | Genetic investigation of Nordic patients with complement-mediated kidney diseases. | Front Immunol | 2023 | https://conductscience.org/library/papers/37744338 | PubMed |
| 34613485 | Complement catalyzing glomerular diseases. | Cell Tissue Res | 2021 | https://conductscience.org/library/papers/34613485 | PubMed |
| 33738291 | Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention. | Front Med (Lausanne) | 2020 | https://conductscience.org/library/papers/33738291 | PubMed |
| 33384694 | Factor H Autoantibodies and Complement-Mediated Diseases. | Front Immunol | 2020 | https://conductscience.org/library/papers/33384694 | PubMed |
| 32540405 | Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome. | Kidney Int | 2020 | https://conductscience.org/library/papers/32540405 | PubMed |
| 31980588 | CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. | J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/31980588 | PubMed |
| 30891033 | Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics. | Front Immunol | 2019 | https://conductscience.org/library/papers/30891033 | PubMed |
| 30552416 | Bevacizumab-associated glomerular microangiopathy. | Mod Pathol | 2019 | https://conductscience.org/library/papers/30552416 | PubMed |
| 28341889 | Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology. | Clin Exp Nephrol | 2018 | https://conductscience.org/library/papers/28341889 | PubMed |
| 28220235 | Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS. | Pediatr Nephrol | 2017 | https://conductscience.org/library/papers/28220235 | PubMed |
| 28025630 | Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern. | Case Rep Nephrol | 2016 | https://conductscience.org/library/papers/28025630 | PubMed |
| 27617140 | The Genetics of Ultra-Rare Renal Disease. | J Pediatr Genet | 2016 | https://conductscience.org/library/papers/27617140 | PubMed |
| 27528699 | Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/27528699 | PubMed |
| 27452363 | Anti-complement-factor H-associated glomerulopathies. | Nat Rev Nephrol | 2016 | https://conductscience.org/library/papers/27452363 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CFH | 3075 | PubTator's text mining | https://conductscience.org/library/genes/3075 | NCBI Gene |
| CFHR1 | 3078 | PubTator's text mining | https://conductscience.org/library/genes/3078 | NCBI Gene |
| CFHR3 | 10878 | PubTator's text mining | https://conductscience.org/library/genes/10878 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20157737
GET https://conductscience.org/api/papers/v1/20157737/references?page=2